Shibani Nicum

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 9

Top Topics

Chemotherapy Induced

Top Venues

British journal of cancer

Journal of gynecologic oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Luke Steventon, Kenneth Keng Cheung Man, Shibani Nicum, Rowan E Miller, Shira Peleg Hasson, Samixa Shah, Michael Baser, Emma Kipps, Martin D Forster, Ofran Almossawi, Pinkie Chambers
The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer. The oncologist (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Shibani Nicum, Naomi McGregor, Rachel Austin, Linda Collins, Susan Dutton, Iain A McNeish, Rosalind M Glasspool, Marcia Hall, Rene Roux, Agnieszka Michael, Andrew Clamp, Gordon Jayson, Rebecca S Kristeleit, Susana Banerjee, Anita Mansouri
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer. British journal of cancer 130 (6) (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Shibani Nicum, Naomi McGregor, Rachel Austin, Linda Collins, Susan Dutton, Iain A McNeish, Rosalind M Glasspool, Marcia Hall, Rene Roux, Agnieszka Michael, Andrew Clamp, Gordon Jayson, Rebecca S Kristeleit, Susana Banerjee, Anita Mansouri
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer. British journal of cancer 130 (6) (2024)
Shibani Nicum, Naomi McGregor, Rachel Austin, Linda Collins, Susan Dutton, Iain A McNeish, Rosalind M Glasspool, Marcia Hall, Rene Roux, Agnieszka Michael, Andrew Clamp, Gordon Jayson, Rebecca S Kristeleit, Susana Banerjee, Anita Mansouri
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer. British journal of cancer (2024)
Shibani Nicum, Naomi McGregor, Rachel Austin, Linda Collins, Susan Dutton, Iain A McNeish, Rosalind M Glasspool, Marcia Hall, Rene Roux, Agnieszka Michael, Andrew Clamp, Gordon Jayson, Rebecca S Kristeleit, Susana Banerjee, Anita Mansouri
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer. British journal of cancer 130 (6) (2024)